Genes and cigarette smoking. by Munafò, MR, Johnstone, E

“… AIMS: Attempts to further our understanding of the determinants of cigarette smoking, tobacco addiction and related behaviours have included the dissection of genetic influences on these phenotypes. …”

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. by David, S, Munafò, MR, Murphy, M, Walton, RT, Johnstone, E

“…The primary outcome measures were biochemically verified sustained abstinence from cigarette smoking at end of treatment and 24-week follow-up. …”

Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers. by Munafò, MR, Mannie, Z, Cowen, P, Harmer, C, McTavish, S

“…In addition, these results also provide further evidence for sex differences in the factors that maintain cigarette smoking, in particular with respect to conditioned reinforcement of smoking behaviour, and suggest that the relationship between subjective craving and selective processing of smoking-related cues may differ in males and females.…”

Lack of association of OPRM1 genotype and smoking cessation. by Munafò, MR, Johnstone, E, Aveyard, P, Marteau, T

“…OPRM1 may have at most only a modest role in explaining cigarette smoking and cessation.</p>…”

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. by David, S, Johnstone, E, Churchman, M, Aveyard, P, Murphy, M, Munafò, MR

“…INTRODUCTION: Cigarette smoking remains the leading cause of preventable death worldwide. …”

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort by Clift, AK, von Ende, A, Tan, PS, Sallis, HM, Lindson, N, Coupland, CAC, Munafò, MR, Aveyard, P, Hippisley-Cox, J, Hopewell, JC

“…Genetically predicted higher number of cigarettes smoked per day was associated with higher risks of all outcomes (infection OR 2.51, 95% CI 1.20 to 5.24; hospitalisation OR 5.08, 95% CI 2.04 to 12.66; and death OR 10.02, 95% CI 2.53 to 39.72).…”